FDA Inspection 1057473 — Wake Forest Institute For Regenerative Medicine
The FDA completed an inspection of Wake Forest Institute For Regenerative Medicine on Jun 21, 2018 in Winston Salem, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 21, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Winston Salem, NC (United States)